Sulfa and trimethoprim-like drugs - antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors.
about
Legionella pneumophila Carbonic Anhydrases: Underexplored Antibacterial Drug TargetsThe anticonvulsant sulfamide JNJ-26990990 and its S,S-dioxide analog strongly inhibit carbonic anhydrases: solution and X-ray crystallographic studiesSynthesis of 4-[2-(3,4-dimethoxybenzyl)cyclopentyl]-1,2-dimethoxybenzene Derivatives and Evaluations of Their Carbonic Anhydrase Isoenzymes Inhibitory Effects.A class of carbonic anhydrase I - selective activators.A class of 4-sulfamoylphenyl-ω-aminoalkyl ethers with effective carbonic anhydrase inhibitory action and antiglaucoma effects.Comparison of the Sulfonamide Inhibition Profiles of the β- and γ-Carbonic Anhydrases from the Pathogenic Bacterium Burkholderia pseudomallei.The η-class carbonic anhydrases as drug targets for antimalarial agents.The history and rationale of using carbonic anhydrase inhibitors in the treatment of peptic ulcers. In memoriam Ioan Puşcaş (1932-2015).A magnificent enzyme superfamily: carbonic anhydrases, their purification and characterization.Sequence Analysis, Kinetic Constants, and Anion Inhibition Profile of the Nacrein-Like Protein (CgiNAP2X1) from the Pacific Oyster Magallana gigas (Ex-Crassostrea gigas).How many carbonic anhydrase inhibition mechanisms exist?Drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors.Inhibition of carbonic anhydrase from Trypanosoma cruzi for the management of Chagas disease: an underexplored therapeutic opportunity.Bacterial Synthesis of Unusual Sulfonamide and Sulfone Antibiotics by Flavoenzyme-Mediated Sulfur Dioxide Capture.Synthesis of pro-apoptotic indapamide derivatives as anticancer agents.Antifungal therapeutics for dimorphic fungal pathogens.Advances in structure-based drug discovery of carbonic anhydrase inhibitors.Open saccharin-based secondary sulfonamides as potent and selective inhibitors of cancer-related carbonic anhydrase IX and XII isoforms.Carbonic Anhydrase from Porphyromonas Gingivalis as a Drug Target.New light on bacterial carbonic anhydrases phylogeny based on the analysis of signal peptide sequences.Challenges and Hallmarks of Establishing Alkylacetylphosphonates as Probes of Bacterial 1-Deoxy-d-xylulose 5-Phosphate Synthase.Expression and characterization of a recombinant psychrophilic γ-carbonic anhydrase (NcoCA) identified in the genome of the Antarctic cyanobacteria belonging to the genus Nostoc.A new procedure for the cloning, expression and purification of the β-carbonic anhydrase from the pathogenic yeast Malassezia globosa, an anti-dandruff drug target.A failed tentative to design a super carbonic anhydrase having the biochemical properties of the most thermostable CA (SspCA) and the fastest (SazCA) enzymes.Protonography, a technique applicable for the analysis of η-carbonic anhydrase activity.Dithiocarbamates with potent inhibitory activity against the Saccharomyces cerevisiae β-carbonic anhydrase.Sublethal Concentrations of Antibiotics Cause Shift to Anaerobic Metabolism in Listeria monocytogenes and Induce Phenotypes Linked to Antibiotic Tolerance.Production and covalent immobilisation of the recombinant bacterial carbonic anhydrase (SspCA) onto magnetic nanoparticles.Biochemical characterization of the native α-carbonic anhydrase purified from the mantle of the Mediterranean mussel, Mytilus galloprovincialis.Cloning, expression and biochemical characterization of a β-carbonic anhydrase from the soil bacterium Enterobacter sp. B13.Inhibition studies of quinazoline-sulfonamide derivatives against the γ-CA (PgiCA) from the pathogenic bacterium, Porphyromonas gingivalis.7-Amino-3,4-dihydro-1H-quinolin-2-one, a compound similar to the substituted coumarins, inhibits α-carbonic anhydrases without hydrolysis of the lactam ring.An Overview of the Bacterial Carbonic Anhydrases.Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors.Synthesis and biological evaluation of benzenesulphonamide-bearing 1,4,5-trisubstituted-1,2,3-triazoles possessing human carbonic anhydrase I, II, IV, and IX inhibitory activity.Synthesis and carbonic anhydrase I, II, VII, and IX inhibition studies with a series of benzo[d]thiazole-5- and 6-sulfonamides.Cloning, expression and purification of the α-carbonic anhydrase from the mantle of the Mediterranean mussel, Mytilus galloprovincialis.Nanoemulsions of sulfonamide carbonic anhydrase inhibitors strongly inhibit the growth of Trypanosoma cruzi.Special Issue: Sulfonamides.Inhibition of the α-carbonic anhydrase from Vibrio cholerae with amides and sulfonamides incorporating imidazole moieties.
P2860
Q26744302-B85B7EC6-25C2-40C6-9587-002AF473F0A8Q27704823-FBB29A20-62AD-4E0A-B91C-1FB189300AF0Q31030668-7F627B41-4259-492B-BF55-783DAB989714Q31140231-1A1A2B8E-5BB8-4C25-AA27-1CA9A3C0961CQ34631556-22D41F14-BBED-42DF-AC6D-112FBDE594B8Q36300465-7CC6C167-AD73-4FBA-A79D-A9575ADB4A9CQ38286239-7F8A657D-FC82-40A0-9B9F-4B4B612C3DE2Q38537265-95E3DE00-C240-47A9-A91B-95D828993215Q38539283-E37DFB6D-BB1F-4845-BD38-50D1286CB2C2Q38605750-FBC2F742-78AD-49D1-8762-26BC514C00D3Q38653464-CF1321A9-B40F-451B-98A3-FADCAA576FBCQ38733892-70C46947-457B-4D38-989F-39A3EC6817A8Q38742510-4DDCE2D8-B4D5-4BDF-8AFE-8297AB32C887Q38835569-53C3EE17-9EA1-449D-B41A-5F39E44F1615Q38909487-ACC3DB49-C5A9-41AF-B57D-D5AA43B69FAEQ38959083-8E0916F6-A518-4565-A42D-BEF6CD5A2750Q38991378-F40A29CF-1009-44D4-8135-1D164C55C5A5Q39246954-BB8C8A6E-201D-4388-A7E6-8014DFBCBF63Q39438781-72AFC4C0-6CF6-48D9-B0C8-8E5C97B3FD19Q39647967-8BBC80CB-EF4E-40A3-81B0-BAB47D9026C7Q40163906-27874536-1F8D-49D7-B8FD-588DC161EF1CQ40677930-F15AF307-B8E3-45B3-B4D6-1D934232955FQ40927627-D8A43DC9-2D80-4981-964D-877EB5619B7BQ41434488-9B95D75E-D143-47C0-8111-F5555F7313CBQ41486816-1225453F-994E-42E6-8124-775F9EDFF7E2Q41491551-58ABC3BB-4DC8-4D7F-AEAF-39246DFF7C22Q42000073-22BEDB2E-2F4C-4372-AF5A-48D74A650014Q43030626-901FEEB8-1F58-4515-A229-526ADE135C93Q46275610-CC3B209B-BE8B-4BBC-900C-0A88BA1AF4E2Q46279624-B62CA10D-6890-4CC9-804B-BC24E150A202Q46544659-17D3FA5D-6154-45EE-99BA-D6174928F036Q46774097-A2061B07-1EA0-4EEE-AF59-6D6935E9673DQ47145746-A540EF52-2E39-49AD-AAF0-47976C931F40Q47719833-00B1281A-D62B-407C-88AD-C570355B44B3Q47824587-3742B4A3-757D-4D6F-AA1B-0AEE9F99C753Q48017394-6FB110F2-8A79-4511-9E1F-22F9DC5E54AEQ48031363-8CC749F8-5C3D-42C9-B0F8-C624F15AFE14Q48205296-307FE229-B0AA-46DB-9B63-2134A1960551Q48268820-1D5744B0-EEDF-4D00-8716-E144B332D828Q48344840-3E103E0D-5D80-43E1-8D0D-3996D1FAA5CA
P2860
Sulfa and trimethoprim-like drugs - antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Sulfa and trimethoprim-like dr ...... rofolate reductase inhibitors.
@en
type
label
Sulfa and trimethoprim-like dr ...... rofolate reductase inhibitors.
@en
prefLabel
Sulfa and trimethoprim-like dr ...... rofolate reductase inhibitors.
@en
P2860
P1476
Sulfa and trimethoprim-like dr ...... rofolate reductase inhibitors.
@en
P2093
Claudiu T Supuran
Clemente Capasso
P2860
P304
P356
10.3109/14756366.2013.787422
P577
2013-04-29T00:00:00Z